Ind Swift Laboratories’ net profit rose 82.97 per cent to Rs 24.61 crore during the third quarter ended December 31, 2010, over the same period previous fiscal.
Net profit during the same period last fiscal stood at Rs 13.45 crore, the company said in a statement.
The company’s turnover also rose 42.9 per cent to Rs 310.11 crore during the quarter under review compared with Rs 216.90 crore in the same period last fiscal.
“The company’s focus on high-end export markets and on block buster molecule is yielding results as the company is giving sustained revenues,” the Ind Swift Laboratories Vice-Chairman-cum-Managing Director, Mr N.R. Munjal, said.
“Going forward, the company is looking at a quantum leap jump in its efforts to tap regulated markets which will improve the quality of our business and deliver strong numbers on a consistent basis,” Mr Munjal added.
Exports during the quarter rose 37.87 per cent to Rs 120 crore from Rs 87.03 crore.
The company shares were trading at Rs 98 on the Bombay Stock Exchange in the late afternoon trade today, up 4.76 from its previous close.